Nikolas Hitiris

Predictors of pharmacoresistant epilepsy

Nikolas Hitiris, Rajiv Mohanraj, John Norrie et al. · Epilepsy Research · 2007 · 521 citations

Medicine, Pharmacology, Pharmacotherapy +11

Mortality in adults with newly diagnosed and chronic epilepsy: a retrospective comparative study

Rajiv Mohanraj, John Norrie, Linda J. Stephen et al. · The Lancet Neurology · 2006 · 246 citations

Medicine, Neurology, Epidemiology +8

The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

Anthony G Marson, Girvan Burnside, Richard Appleton et al. · The Lancet · 2021 · 211 citations · Full text

Medicine, Neurology, Pharmacology +17

The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

Anthony G Marson, Girvan Burnside, Richard Appleton et al. · The Lancet · 2021 · 191 citations · Full text

Medicine, Neurology, Pharmacotherapy +15

Sudden unexpected death in epilepsy: A search for risk factors

Nikolas Hitiris, Suraya Suratman, Kevin Kelly et al. · Epilepsy & Behavior · 2006 · 153 citations

Medicine, Emergency Medicine, Neurology +14